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Abstract
Objectives To quantify airway and artery (AA)-dimensions in
cystic fibrosis (CF) and control patients for objective CT di-
agnosis of bronchiectasis and airway wall thickness (AWT).
Methods Spirometer-guided inspiratory and expiratory CTs of
11 CF and 12 control patients were collected retrospectively.
Airway pathways were annotated semi-automatically to re-
construct three-dimensional bronchial trees. All visible AA-
pairs were measured perpendicular to the airway axis. Inner,
outer and AWT (outer−inner) diameter were divided by the
adjacent artery diameter to compute AinA-, AoutA- and AWTA-
ratios. AA-ratios were predicted using mixed-effects models
including disease status, lung volume, gender, height and age
as covariates.
Results Demographics did not differ significantly between
cohorts. Mean AA-pairs CF: 299 inspiratory; 82 expiratory.
Controls: 131 inspiratory; 58 expiratory. All ratios were sig-
nificantly larger in inspiratory compared to expiratory CTs for
both groups (p<0.001). AoutA- and AWTA-ratios were larger in
CF than in controls, independent of lung volume (p<0.01).
Difference of AoutA- and AWTA-ratios between patients with
CF and controls increased significantly for every following
airway generation (p<0.001).
Conclusion Diagnosis of bronchiectasis is highly dependent
on lung volume and more reliably diagnosed using outer air-
way diameter. Difference in bronchiectasis and AWT severity
between the two cohorts increased with each airway
generation.
Key points
• More peripheral airways are visible in CF patients com-
pared to controls.
• Structural lung changes in CF patients are greater with each
airway generation.
• Number of airways visualized on CTcould quantify CF lung
disease.
• For objective airway disease quantification on CT, lung
volume standardization is required.
Keywords Cystic fibrosis . Imaging/CT . Paediatric lung
disease . Bronchiectasis . Airway dimensions
Introduction
In cystic fibrosis (CF) lung disease is characterized by pro-
gressive bronchiectasis (BE) and airway wall thickening
(AWT) [1–3]. Chest computed tomography (CT) is the most
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sensitive tool for diagnosing BE and AWT, which are impor-
tant outcome measures for both clinical and research purposes
[1, 4].
BE is defined as destructive and irreversible widening of
airways with a ratio between airway and accompanying artery
(AA) above 1 in adults [5, 6]. Currently, the inner airway
dimensions are mostly used for comparison with the artery
[7–9]. However, no clear consensus, based on objective quan-
titative measures, exists on whether inner or outer airway di-
ameter should be compared with the artery for the diagnosis of
BE [10]. Nonetheless, the approximate ratio of 1 was based on
the outer airway diameter [11]. In addition, it is not clear
whether identical AA-ratio cutoffs can be used to define BE
in children, where a smaller AA-ratio has been suggested [5].
Lastly, the AA-ratio is thought to increase with age in healthy
subjects [12].
AWT like BE is associated with airway inflammation
[13, 14]. AWT is presumed to be present when the airway
wall diameter occupies more than 20% of the total outer
airway diameter [15] or takes up more than 33% of the
adjacent arterial diameter [8]. CT assessments of BE and
AWT are mostly performed in the axial or coronal plane
by comparing airway diameter to the accompanying artery
diameter. However, to avoid inaccuracy caused by the par-
allax or projection error, the AA dimensions should ideally
be evaluated in a view perpendicular to the airway centre-
line [16–18].
Airway dimensions are routinely evaluated on inspiratory
CT [19]. Unfortunately lung volume levels during inspiratory
CT acquisition have been shown to vary widely between 55%
and 106% of the measured total lung capacity (TLC) obtained
via body plethysmograph [20]. This variability is caused by a
lack of breath-hold standardization and influences the AA-
ratio and therefore diagnosis of bronchiectasis [7, 21, 22].
Airway dimensions assessed on axial view were shown to
be highly dependent on the lung volume levels in children
below the age of 5 years with CF [7], in adults with chronic
obstructive pulmonary disease (COPD) [23, 24], and in
healthy controls [22]. Hence, suboptimal lung volume levels
negatively impact objective evaluation of BE and AWT.
The purpose of our study was to develop objective criteria
to diagnosis BE and AWT in children by comparing AA di-
mensions between CF patients and control patients with
spirometer-guided CTs. We hypothesized that AA-ratios are
increased in paediatric CF patients and more prominent on
inspiratory CTs. To investigate this, we aimed to assess: (1)
AA dimensions in control patients; (2) use of inner or outer
airway diameter as a more sensitive biomarker to diagnose
BE; and (3) influence of inspiratory and expiratory CTs on
AA dimensions. Between CF and control patients we aimed
to assess: (4) differences in the number of visible AA-pairs
and AA dimensions; and (5) differences according to airway
location (e.g. lobes and airway generations).
Materials and methods
This study was approved by the Institutional Review Board
(MEC-2014-254). Written informed consent was waived for
all patients because of the retrospective nature of the study.
Study population
Spirometer-guided inspiratory and expiratory chest CTs of 11
CF patients and 12 control patients without lung abnormalities
on CT made between 2007 and 2012 were selected retrospec-
tively. All patients were treated at Erasmus MC-Sophia
Children’s Hospital.
CF patients
Inclusion criteria: diagnosis of CF; age between age 6 and 16
years; spirometer-guided chest CT acquired with
SOMATOM® Definition Flash CT scanner (Siemens
Healthcare, Forchheim, Germany); slow vital capacity during
CT for inspiratory CT ≥85% and expiratory CT ≥80% as
recommended and described by Salamon et al. [25].
Exclusion criteria: poor image quality due to motion artifacts;
poor breath- hold performance as judged by a lung function
technician. Twelve CF patients were randomly selected out of
all patients that met the selection criteria.
Control patients
Inclusion criteria: good or excellent spirometer-guided chest
CT acquired with SOMATOM® Definition Flash scanner;
clinical reason for CT other than CF; report by Erasmus MC
radiologist stating chest CT to be normal; defined normal on
second reading by an independent radiologist (CY, 20 years of
experience in thoracic imaging) blinded to patient identifiers
and information. Out of 16 control chest CTs that met the
above-mentioned criteria, 12 CTs were selected with best
matched ages of the CF group. More detailed control group
characteristics are provided in Table 1.
CT scanning
End-inspiratory and end-expiratory volumetric chest CTs
were obtained in the supine position. Details of scan parame-
ters are provided in Table 2.
Quantitative analysis of airways and arteries
All CTs were scored in random order using the CF-CTscoring
system to quantify structural CT abnormalities in CF and
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controls as described in more detail separately [26].
Dimensions of AA-pairs were measured using Myrian®
(v1.16.2, Lung XP module) image analysis platform
(Intrasense, Montpelier, France) as described previously
[26]. In summary, airway pathways were indicated automati-
cally. Pathways of additional lobar, segmental and
subsegmental airways not automatically indicated were added
manually. The bronchial tree was reconstructed in a 3D-view
(Online Supplementary Material, video E1), and cross-
sectional CT reconstructions were generated based on the air-
way’s centre-line (Fig. 1). One measurement per branch was
made when both airways and artery were clearly visible. AA-
pairs with movement artefacts or too much noise for reliable
measurements were excluded. In addition, AA-pairs of air-
ways that did not show a visible inner lumen (e.g. due to
mucous plugging) and airways without a clear identifiable
adjacent artery (e.g. due to atelectasis or severe cystic bron-
chiectasis without a traceable artery) were excluded.
Inner and outer airway diameters were divided by artery
diameter to compute AinA and AoutA-ratio, respectively. Wall
thickness (difference between outer and inner airway diame-
ter) was divided by outer airway diameter to compute AWT-
ratio and divided by artery diameter to compute AWTA-ratio.
Location of airway artery measures
The lung lobes (right upper (RUL), right middle (RML), right
lower (RLL), left upper (LUL), left lower lobe (LLL) and
lingula (LING)), segmental bronchi (nomenclature as
depicted by Netter [27]), and airway generations were
annotated for each AA measurement. Airway generation
started at the trachea as 0, the main stem bronchi as 1 and
continuing after each time the bronchi bifurcates. The upper
segmental bronchi begins at generation 3–4 and lower seg-
mental bronchi begins at generation 4–7. The generation from
each segmental bronchi as described in Online Supplementary
Material Fig. E2a was subtracted from the airway generation
to compute the segmental generation starting at 1 (see Fig. 2).
Segmental generations ≥4 were defined as peripheral airways
for the purpose of this paper.
Observer reliability
CTs of all patients were anonymized and randomized before
scoring. The scorers were blinded to all clinical information.
All AA measurements were conducted by the first observer
(WK, 3 years of experience). After 3 months, a total of 386
measurements were repeated in one randomly selected seg-
mental branch of every patient to establish intra-observer var-
iability. A second observer measured a total of 2945 AA di-
mensions in a random subset of 25 CTs (HO, 1 year of expe-
rience) in order to determine interobserver variability.
Statistical analysis
Differences between patient characteristics in the two cohorts
were assessed with the Mann–Whitney U test. Differences in
number of AA-pairs visible were assessed using theWilcoxon
Table 2 Scan parameters used to obtain the CTs
CF subjects Control subjects
Scan acquisition Inspiration Expiration Inspiration Expiration
Tube voltage (kV) 80 80 (80–120) (80–120)
Pitch 0.85 0.85 0.85 0.85
Slice thickness (mm), median (range) 1 (0.75–1) 1 (0.75–1) 1 1
Reconstruction increment (mm), median (range) 0.6 (0.3–1) 0.6 (0.3–1) 0.8 (0.6–0.8) 0.8 (0.6–0.8)
Reconstruction kernel B70f;B75f B70f;B75f B75f; I70f B75f;I50f
Collimation 128x0.6 128x0.6 128x0.6 128x0.6
Current-time product (mAs), median (range) 46 (36–52) 44 (35–53) 28 (11–61) 23 (8–65)
CTDIvol,32 cm (mGy), median (range) 0.74 (0.57–0.83) 0.71 (0.56–0.84) 0.76 (0.32–1.13) 0.56 (0.24–1.05)
DLP(mGy * cm), median (range) 21 (14–28) 17 (11–25) 22.5 (7–38) 14.5 (5–30)
Table 1 Diagnosis of control subjects
Clinical diagnosis Reason for CT Findings No. of subjects
Asthma Air trapping, bronchiectasis, malacia? No air trapping, no bronchiectasis, no malacia 8
Recurrent respiratory infections Air trapping, bronchiectasis, malacia? No air trapping, no bronchiectasis, no malacia 3
Condition after oesophageal atresia Tracheomalacia? No tracheomalacia 1
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signed-rank test. The relationship between number of AA-
pairs visible with height and age was evaluated with linear
regression analysis. Mixed-effect models were used to pre-
dict AA-ratios using disease status and lung volume.
Influence of other covariates (i.e. gender, age and height)
on AA-ratios was assessed univariately. Univariate covari-
ates found to be significant were added with interaction to
the main model. Variable selection in the main model was
performed with a likelihood ratio test. Mixed-effect models
were used to evaluate differences between CF and control
patients and volume level predicting AA-ratios for each
segmental generation and lung lobes. Random-effects of
lobes and individuals were included in all mixed-effect
models to capture heterogeneity.
For diagnosis of bronchiectasis receiver operating charac-
teristic (ROC) curves with the corresponding areas the under
curve (AUCs) and 95% confidence interval (CI) were plotted
to identify the threshold values for AinA and AoutA-ratios with
the highest combined sensitivity and specificity. The intraclass
correlation coefficient (ICC) was used to measure inter- and
intra-observer agreement, with the use of mixed-effects
models. In these mixed-effects models the structure was taken
into account, specifically the segmental branches within gen-
eration within patients. ICC values between 0.4 and 0.6, 0.6
and 0.8, or ≥ 0.8 were considered to indicate moderate, good,
and very good agreement, respectively [28].
Results were expressed as median and interquartile range
(IQR). A p-value of 0.05 or less was considered significant.
All analyses were conducted using R version 3.1.0 [29].
Results
Study population
A detailed description of the group characteristics is shown
in Table 3. One subject in the CF group was excluded after
image analysis since the patient appeared to be mislabeled
and diagnosed with common variable immunodeficiency.
Hence, 11 patients with CF (six males) were included for
further analysis with a median age of 11 years. Twelve con-
trol patients with normal CTs (seven males) were included
with a median age 13.9 years. All but one control patient
had spirometry performed on the same day or maximally 1
month apart from the CT scan. One control patient did not
have a recent spirometry available, so spirometry of 8
months prior to the CT was used. Re-analysis without this
subject did not influence differences between the groups in
demographics or spirometry. No significant difference was
found in age, gender, height, weight and PFTs between the
two groups. All CF-CT scores were significantly higher in
the CF compared to the control group.
Quantitative analysis of airways and arteries
A total of 6,464 AA-pairs were measured in perpendicular
view of the airway axis. In CF patients a mean of 299 AA-
pairs were measured on end-inspiration and 82 AA-pairs on
the end-expiration CTs. In control patients a mean of 131
pairs were measured on end-inspiration and 58 AA-pairs on
the end-expiration CTs. Number of visible AA-pairs was
significantly higher in inspiration compared to expiration
Fig. 2 The segmental branches are shown in the different colours and the
numbering stands for each segmental airway generation. The segmental
generation ensured all segmental bronchi started at segmental generation
1 to avoid discrepancies in the upper and lower segmental airway
generations as demonstrated in Online Supplementary Material Fig. E2
(Artist: K. Rubenis)
Fig. 1 The three measurements of the airway and accompanying artery
in a perpendicular view to the pathway centre-line, using an ellipse image
analysis tool (Myrian®). The annotated surface areas of the inner (#3) and
outer (#2) airway and of the artery (#1) were used to estimate diameters
and to calculate the AA-ratios. The location of all AA-pairs was deter-
mined by using 3D segmentation (videos of rotating 3D segmentations in
colour can be found in Online Supplementary Material E2)
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CTs in both CF and control groups (p<0.001). This differ-
ence is especially prominent after segmental generation 4
(Fig. 3). CF patients had significantly more visible AA-
pairs (p<0.001) than controls in inspiratory CTs, but not in
expiratory CTs (p=0.54). As seen in Fig. 3, patients with CF
have a large number of visible AA-pairs in higher genera-
tions (8–12), whereas control patients had none. Number of
AA-pairs counted was not correlated with age (p=0.72) or
height (p=0.77).
Airway-artery dimensions
Median (range) of the inner, outer, wall and vessel diameter
were 1.65 (0.36–6.58), 3.74 (1.00–9.84), 2.08 (0.50–6.28) and
3.42 (0.94–11.99) mm, respectively (Online Supplementary
Material Fig. E3). AinA- and AoutA-ratio was independent of
age in both CF and control patients (Fig. 4). Gender, age and
height were not significantly related to AinA, AoutA or AWTA-
ratio in a univariate mixed-effect model. Height, but not gen-
der and age, was found to be significant in the mixed-effect
model with AWT-ratio (p=0.001), so height was included in the
model describing AWT-ratio.
AinA, AoutA, AWT and AWTA-ratios differed significantly
on inspiratory CTs compared to expiratory CTs for both CF
and control groups (P<0.001). The significant differences in
AA- and AWT-ratios between CF and control patients are
shown in Table 4.
Comparison of CF versus control group
The optimal threshold to define BE was reached at a value of
0.5 for AinA-ratio and 1.11 for AoutA-ratio. AUC (95%CI) for
AinAwas 0.6 (0.59–0.61) and 0.72 (0.71–0.74) for AoutA-ratio
(Online Supplementary Material Fig. E4). The optimal thresh-
old for BE of peripheral airways (segmental generation ≥4)
was 0.56 for AinA-ratio (AUC 0.63, 95% CI 0.61–0.65) and
1.17 for AoutA-ratio (AUC 0.75, 95% CI 0.73–0.77).
Location of airway and artery measures
Figure 5a and b show AoutA and AWTA-ratio by segmental
generation. The difference in AoutA and AWTA-ratio between
inspiratory CF and controls was significant for segmental gen-
eration 2–6 (p≤0.02). Difference in AoutA between patients
with CF and control patients became larger with each follow-
ing segmental generation. AinA and AWT-ratio did not differ-
entiate significantly between the CF and control group on
inspiratory CT in each segmental generation (Fig. 5c, d).
More detail on the differences and significance values for each
segmental generation can be found in Online Supplemental
Material Table E1a-d.
Quantitatively, bronchiectasis has an upper lobe predomi-
nance. Online Supplemental Material Table E2a-d shows the
detailed results of the mixed-effect model regarding the dif-
ferent lung lobes. In both CF and control patients, AoutA-,
Table 3 Demographics of the
cystic fibrosis (CF) and normal
cohorts
Patients with CF, median
(IQR)
Control patients, median
(IQR)
P-value
Age at CT (years) 11 (9.3–11.1) 13.9 (8.7–15) 0.385
Age at force (years) 11 (9.3–13) 13.9 (8.7–15) 0.385
Time between CT and PFT
(months)
0.0 (0.0–0.0) 0.5 (0.1–0.7) 0.011*
Gender 6 males; 5 females 7 males; 5 females 0.808
Height (cm) 144.4 (138.2–146.8) 149 (136.6–170.9) 0.296
Weight (kg) 34.5 (30.4–45.3) 40.1 (28.6–65.8) 0.461
BMI 17.5 (15.5–19.4) 18.1 (15.9–20.2) 0.435
CF-CT BE score (%) 5.2 (1.4–12.1) 0.0 (0.0–0.7) <0.001*
CF-CTAWT score (%) 5.6 (0.0–19.3) 0.0 (0.0–0.0) <0.001*
CF-CT MP score (%) 2.8 (0.0–22.9) 0.0 (0.0–0.0) <0.001*
CF-CTAT score (%) 51.2 (25.9–66.7) 3.7 (0.0–8.3) <0.001*
CF-CT total score (%) 7.8 (6.2–18.4) 1.2 (0.4–1.4) <0.001*
FEV1 (z-scores) − -1.3 (− -2.2–0.1) − -1.7 (− -2.1– -0.4) 0.668
FVC (z-scores) − -0.1 (− -1.2–0.8) − -0.4 (− -2.3–0.8) 0.409
FEV1/FVC 0.82 (0.76–0.83) 0.82 (0.70–0.91) 0.385
FEF25–75 (z-scores) − -1.8 (− -2.3– -0.6) − -1.4 (− -2.5– -1) 0.939
Wilcoxon signed rank test to test the difference in demographics between the CF and control group. CF-CTscores
ofmucous plugging (MP), air trapping (AT), and the total score were compared as well as CF-CTscores of BE and
AWT. Spirometry was compared using Z-scores according to Quanjer et al. [41]
PFT pulmonary function test, BMI body mass index, FEV1 forced expiratory flow in 1 s, FVC forced vital
capacity, FEF25-75 forced expiratory flow during the 25-75% portion of the FVC
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AWTA- and AWT-ratio were significantly higher in RUL com-
pared to all other lobes (p<0.001). In CF patients, AoutA- and
AWTA-ratio was significantly higher in LUL compared to right
middle lobe (RML), right lower lobe (RLL) and left lower
lobe (LLL) (p<0.001). LLL was significant lower than all
other lobes for AoutA-, AWTA-, and AWT-ratio in CF patients
(p≤0.004).
Reproducibility of airway measurements
For the interobserver variability, ICC for AA dimensions were
as follows: Inner airway (0.69), outer airway (0.72), wall
(0.66) and vessel diameter (0.69). For the intra-observer var-
iability, ICC for the different dimensions were as follows:
Inner airway (0.70), outer airway (0.74), wall (0.71) and ves-
sel diameter (0.79).
Discussion
To our knowledge, this is the first study measuring all visible
AA-pairs perpendicular to airway centre-lines in maximal in-
spiration and expiration CTs of CF patients and control pa-
tients. Major differences were observed in number of visible
AA-pairs and in AA-ratios between inspiratory and expiratory
CTs and between CF patients and control patients.
Our study showed that end-inspiratory CTs were most sen-
sitive to detect structural airway disease. Overall two to three
Fig. 4 The AA-ratio is plotted as
a function of age, for AinA (left)
and AoutA (right). The cystic fi-
brosis (CF) patients are depicted
as blackX and dashed line and the
control patients as grey O and
solid lines. AinA-ratio remained
constant with increasing age in
the CF (value=0.010, p=0.28) and
control (value=0.006, p=0.22)
groups. The AoutA-ratio in the CF
group (value=0.026, p=0.10) and
control group (value=0.002,
p=0.52) also did not increase sig-
nificantly with age
Fig. 3 Average number of AA-
pairs visible per segmental gener-
ation for controls (green) and
cystic fibrosis (CF) patients (red),
separated by inspiratory (light
colours) and expiratory (dark col-
ours) CT. Note that the total
number of visible airways on the
inspiratory scans in CF is in-
creased relative to controls
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times more AA-pairs were detected on end-inspiratory CTs of
a patient with CF than on CTs of controls. Difference in num-
ber of visible AA-pairs became more striking with each gen-
eration. Beyond the seventh segmental generation, AA-pairs
were still visible in CF but not in control patients. Our study
confirms that number visible of AA-pairs could be used as a
surrogate outcome for bronchiectasis [26, 30–32].
Nevertheless, it is important to keep in mind that the number
of visible airways can be affected by patient size as well as
inspiration level and scan protocol. In this study, patient size
did not influence the number of AA-pairs counted and scan
protocol did not play a role as inspiratory CTs of both CF and
Fig. 5 Boxplots of the AA-ratios in the control group (green) and in the
cystic fibrosis (CF) group (red) for each segmental generation. Inspiratory
scans are shown in light colours and expiratory scans in dark colours.
Each box shows median (horizontal line), interquartile range (solid box),
1.5*interquartile range (whiskers) and outliers (points). aWhen focusing
on the inspiratory scans, an increasing difference can be found in AoutA-
ratio between the CF and control group from generation 2 to generation 6
(increasing difference of 0.08–0.19, p≤0.02). The difference between CF
and the control group of the AoutA-ratio in the expiratory scans was found
to be significant from generation 2 to 5 (difference of 0.13–0.15, p≤0.04).
b On the inspiratory scans, a difference can be found in AWTA-ratio
between the cystic fibrosis (CF) and control groups starting from segmen-
tal generation 1 to 6 (difference of 0.05–0.12, p≤0.04). The difference in
AWTA-ratio between CF and the control group in the expiratory scans was
found to be significant from generation 1 to 5 (difference of 0.08–0.13,
p≤0.003). c There was no difference in AinA-ratio between the cystic
fibrosis (CF) and control groups on inspiratory CTs (p≥0.08), neither
was there for the expiratory scans (p≥0.28). A difference in AinA-ratio
was observed between inspiration and expiration CTs of both the CF
(difference of 0.12–0.20, p≤0.04) and control group (difference of
0.13–0.14, p≤0.001). d There was no difference in AWT-ratio between
the cystic fibrosis (CF) and control groups in all segmental generations
on the inspiratory CTs. On expiratory CTs only a difference was found in
segmental generation 1 (difference of 0.05, p=0.021). An apparent differ-
ence was found between inspiratory and expiratory scans in AWT-ratio for
the CF group (0.08–0.11, p≤0.001), as well for the control group (0.09–
0.15, p≤0.001) in all segmental generations (all absolute values can be
found in Online Supplemental Material Table E1a–d)
Table 4 Comparison of airway
dimensions between cystic
fibrosis (CF) patients and controls
Significant difference between disease status (Control/
CF)
AinA-
ratio
AoutA-
ratio
AWTA-
ratio
AWT-
ratio
Inspiration 0.156 <0.001* <0.001* 0.215
Expiration 0.996 0.003* <0.001* 0.036*
P-values of mixed-effect model analysis of differences between airway dimensions between CF and control
patients. AoutA and AWTA -ratios were higher in CF patients than controls in both inspiratory and expiratory
scans. AinA-ratios was not significant and the AWT-ratio only in the expiratory subgroup
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control patients were scanned using the same scanner and
protocols.
AoutA and AWTA-ratios on inspiratory CTs progressively
increased with segmental generation in CF subjects, while
they remained relatively constant over generations in control
subjects. Increased AA-ratios and higher number of visible
peripheral airways suggests more structural abnormalities
due to CF lung disease in the more peripheral airways com-
pared to central airways. These are findings that to our knowl-
edge have not been established by quantitative assessment
previously and strongly support the importance of peripheral
airways in CF lung disease [32–35]. An increase in visible
AA-pairs or in AA-ratios might, however, easily be missed
on visual routine CT.
AA-ratio based on outer airway diameter was more sensi-
tive to detect BE compared to inner diameter as demonstrated
by the higher AUC in the ROC curve. Furthermore, the AoutA-
ratio was less influenced by the inspiration level compared to
the AinA-ratio. Lastly, AinA-ratio could not differentiate be-
tween CF and controls within all segmental generations. This
can be explained by simultaneous airway wall thickening due
to inflammation and mucus impaction, leading to decreased
AinA-ratio. This finding supports previous [11] and recently
published guidelines [12, 26] that rely on outer airway diam-
eter for diagnosis of bronchiectasis on CT. A lower AA-ratio
was reported in children by Kapur et al. [5], but this was based
on the inner luminal diameter instead of the outer diameter. In
our dataset, an AA-ratio based on an outer diameter of 1.1 was
optimal to differentiate between normal and abnormal.
However, AoutA-ratios above 1.1 were found in the control
group as well.
Number of AA-pairs visible and AA-ratios between the
groups were only significantly different in end-inspiration
and not in end-expiration CT. Additionally AWT values were
higher in end-expiratory CTs, possibly due to folding of the
airways in expiration [33]. Thus, in case an ‘inspiratory’ CT is
performed below TLC, number of bronchiectatic airways will
be underestimated. On the other hand AWT increased and
became more apparent in end-expiratory. Hence, when lung
volume is below TLC during CT acquisition, AWT could be
overestimated. These findings strongly support the need for
volume control during acquisition to allow consistent, sensi-
tive and objective detection of BE and AWT [7, 25].
In control patients the AA-ratio did not change significant-
ly with age, as also reported in previous studies [5, 21]. In CF
a trend was observed of an increasing AoutA-ratio with age,
which can be due to disease progression. Nevertheless, we
dealt with a small sample size, thus a larger study population
is needed to investigate changes in the AA-ratios according to
age.
Higher AoutA-ratios were observed in the upper lobes, es-
pecially the RUL. This observation is in in accord with previ-
ous publications observing more severe abnormalities and
inflammation in the RUL of CF patients [13, 36, 37]. Hence,
bronchiectasis detection most likely has to take lobes into
account. Intra-subject differences in airway dimensions be-
tween lung lobes have previously been reported in COPD
patients [23, 24, 38] and control subjects [22].
Our study has several limitations. First, the control pa-
tients were not healthy as they were referred for chest CT
through the paediatric respiratory department. Even though
all CTs were reported to be normal by two independent
radiologists, we cannot exclude that subtle changes in AA
dimensions could have influenced our comparisons.
Secondly, scan and reconstruction parameters were not
identical in all CTs of this retrospective study. In theory this
could have caused a small bias, but we believe this bias to be
small at most since there was no automated post-processing
involved in detecting the airway and artery dimensions, but
instead they were measured manually with an ellipse tool.
However, it is unlikely that these limitations can explain the
large differences found between CF and control patients.
Importantly, a constant AA-ratio was observed for each air-
way generation in control patients while this ratio steadily
increased in CF. Moreover, the CF-CT scored almost no
abnormalities in control subjects, except for some trapped
air which can be physiological in healthy patients [39]. A
second limitation is that we only studied a relatively small
population. This was due to the time needed to manually
score all 48 inspiratory and expiratory CTs (average of
15 h per scan). However, a large number of AA-pairs could
be measured to test our research questions. Thirdly, radia-
tion dose for expiratory CTs was lowered after 2012 in five
out of 12 control patients. This reduced the sensitivity of
measurements and could have reduced the number of visi-
ble AA-pairs, leading to overestimation of the effect of in-
spiration level in control patients. Finally, reproducibility of
single AA measurements was hard to assess as repeated
manual measurements were unlikely to be measured at iden-
tical anatomical locations, causing variability. However
ICCs showed good inter- and intra-observer agreements.
In conclusion, the results of this study showed greater
structural lung changes with each airway generation on chest
CTs of children with CF. In children with CF, more airways
were visible on CT due to the increase of AA-ratios in the
peripheral part of the lungs. For diagnosis and quantification
of BE outer airway diameter should be used, as this is a better
differentiator between CF and control patients. Our findings
strongly support the need for volume standardization in chest
CTs of children aged 6 years and above, for objective and
sensitive evaluation of airway dimensions [7]. To generate
reference values for airway dimensions in children, a larger
study population of normal chest CTs acquired at TLC is
needed. Automatic methods to quantify bronchiectasis are in
development to support clinicians’ diagnosis and reduce the
time of annotations [40].
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